Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US

被引：0
|
作者：
Sundar Jagannath
Nedra Joseph
Jinghua He
Concetta Crivera
Alex Z. Fu
Ashraf Garret
Nina Shah
机构：
[1] Icahn School of Medicine at Mount Sinai,Real World Value and Evidence (Oncology)
[2] Janssen Scientific Affairs,undefined
[3] LLC,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Georgetown University Medical Center,undefined
[7] Legend Biotech Inc.,undefined
[8] University of California San Francisco,undefined
来源：
Oncology and Therapy | 2021年 / 9卷
关键词：
Healthcare costs; Healthcare resource utilization; Multiple myeloma; Triple class exposure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：659 / 669
页数：10
相关论文
共 50 条
  • [31] Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
    Ailawadhi, Sikander
    Delea, Thomas
    Moynahan, Aaron
    Ge, Wenzhen
    Hampp, Christian
    Archambault, Alexi
    Wu, Ning
    Lorenc, Karen Rodriguez
    Noguera-Troise, Irene
    Kroog, Glenn S.
    Houvras, Yariv
    Ma, Qiufei
    BLOOD, 2023, 142
  • [32] Real-World Clinical Outcomes Among Triple-Class Exposed Multiple Myeloma Patients and Subgroups in the US Oncology Network
    Rifkin, Robert M.
    Harper, Jennifer S.
    Le, Hoa H.
    Fu, Alex Z.
    Patel, Saurabh N.
    Zhang, Xinke
    Zackon, Ira L.
    BLOOD, 2023, 142
  • [33] Healthcare Resource Use and Costs Among Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
    Romanus, Dorothy
    Seal, Brian
    Jhaveri, Mehul
    Labotka, Richard
    Henk, Henry
    BLOOD, 2015, 126 (23)
  • [34] Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore
    Bayani, Diana Beatriz
    Lin, Yihao Clement
    Ooi, Melissa G.
    Tso, Allison Ching Yee
    Wee, Hwee Lin
    EJHAEM, 2023, 4 (04): : 1013 - 1018
  • [35] Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events
    Ailawadhi, Sikander
    Medhekar, Rohan
    Princic, Nicole
    Fowler, Robert
    Tran, Oth
    Bhowmik, Debajyoti
    Panjabi, Sumeet
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1070 - 1079
  • [36] Treatment Options for Triple-class Refractory Multiple Myeloma
    Mikhael, Joseph
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : 1 - 7
  • [37] Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study
    Wang, Peter Feng
    Yee, Christopher W.
    Gorsh, Boris
    Zichlin, Miriam L.
    Paka, Prani
    Bhak, Rachel H.
    Boytsov, Natalie
    Khanal, Anamika
    Noman, Ahmed
    DerSarkissian, Maral
    Ferrante, Shannon
    Duh, Mei Sheng
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 398 - 406
  • [38] HEALTHCARE RESOURCE UTILIZATION BURDEN IN THE MANAGEMENT OF TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RESULTS FROM THE ITEMISE STUDY
    Rodriguez Otero, P.
    Dhanasiri, S.
    Hollier-Hann, G.
    Stothard, C.
    Davies, F. E.
    Dhanda, D. S.
    VALUE IN HEALTH, 2021, 24 : S30 - S30
  • [39] Comparative effectiveness of linvoseltamab versus standard-of-care (SOC) treatment (tx) in real-world patients (pts) in the United States (US) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
    Kumar, Shaji
    Weisel, Katja C.
    Ma, Qiufei
    Hampp, Christian
    Humblet, Olivier
    Shokoohi, Mostafa
    Bonar, Nicolle
    Spin, Paul
    Harnett, James
    Ge, Wenzhen
    Jalbert, Jessica J.
    Sobel, Rachel E.
    Kroog, Glenn Scott
    Rodriguez-Lorenc, Karen
    Jagannath, Sundar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma
    Zanwar, Saurabh
    Ho, Matthew
    Kapoor, Prashant
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Kourelis, Taxiarchis
    Fonder, Amie
    Hobbs, Miriam
    Hwa, Yi
    Gonsalves, Wilson
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji
    LEUKEMIA, 2022, 36 (03) : 873 - 876
12345